Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Nanatinostat is an inhibitor of histone deacetylases (HDACs).1 It selectively inhibits HDAC1, HDAC2, and HDAC3 over HDAC5 and HDAC6 (IC50s = 3, 4, 7, 200, and 2,100 nM, respectively). Nanatinostat inhibits proliferation in a panel of 15 cancer cell lines (GI50s = 31-750 nM). It induces cell cycle arrest at the sub-G1 and G2/M phases and induces apoptosis in HCT116 colorectal cancer cells when used at a concentration of 3 µM. Nanatinostat (50 mg/kg per day) decreases tumor volume in an HCT116 mouse xenograft model.
WARNING This product is not for human or veterinary use.
1. Discovery of 2-